Select Publications

Book Chapters

Appay V; Sauce D; Kelleher AD, 2019, 'HIV Infection as a Model of Accelerated Immunosenescence', in Handbook of Immunosenescence, Springer International Publishing, pp. 1961 - 1989,

Ognenovska K; Klemm V; Ledger S; Turville S; Symonds G; Kelleher A; Ahlenstiel CL, 2018, 'Mechanisms for Controlling HIV-1 infection: a Gene Therapy Approach', in In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders,

Appay V; Sauce D; Kelleher A, 2017, 'HIV Infection as a Model of Accelerated Immunosenescence.', in Bachtarzi H (ed.), Handbook of Immunosenescence Basic Understanding and Clinical Implications,

Pinto A; Kelleher AD; Cooper DA, 2014, 'AIDS : Clinical Manifestations', in Encyclopaedia of Life Sciences, John Wiley & Sons,

Alford J; Kelleher A, 2013, 'The Immunocompromised Patient', in Fulde G; Fulde S (ed.), Emergency Medicine: the Principles of Practice, Churchill Livingston, Sydney, pp. 862 - 889,

Kelleher AD; Cooper DA, 2012, 'Chapter 6 Acute HIV infection', in Sande's HIV/AIDS Medicine, Elsevier, pp. 77 - 88,

Kelleher A; Kelly M, 2009, 'Immune Restoration Diseases', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, pp. 287 - 294

Alford J; Kelleher AD, 2009, 'The immunosuppressed patient', in Fulde G (ed.), Emergency Medicine, the Principles of Practice, edn. 5th, Elsevier, Australia, pp. 665 - 686,

Alford J; Kelleher A, 2009, 'The immunosuppressed patient', in Emergency Medicine, Elsevier, pp. 665 - 686,

Kelleher AD; Cooper DA, 2008, 'Acute HIV Infection', in Volberding PA; Sande MA; Greene WC; Lange JMA (ed.), Global HIV/AIDS Medicine, Elsevier Inc, Philadelphia, PA, pp. 63 - 74,

Kelleher AD; Cooper DA, 2008, 'CHAPTER 6 Acute HIV Infection', in Global HIV/AIDS Medicine, Elsevier, pp. 63 - 74,

Ramacciotti TP; Kelleher AD; Cooper DA, 2008, 'Infeccion primaria por HIV. [Primary HIV-1 Infection]', in Benettuci JA (ed.), SIDA y Enfermedades Associadas (AIDS and Infectious Diseases), 3a edicion., edn. 3rd, FUNDAI, Buenos Aires, pp. 155 - 170

Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, edn. Original, Thieme, Stuttgart, pp. 48 - 63

Kelleher A; Orth D, 1997, 'Early HIV-induced immune depletion', in Stewart GJ (ed.), Managing HIV, Medical Journal of Australia

Stewart GJ; Irvine SS; Scott M; Kelleher A; Marriot D; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1997, 'Strategies in managing HIV', in Stewart GJ (ed.), Managing HIV

Journal articles

Duette G; Cronin S; Kelleher AD; Palmer S, 2023, 'Viral competition assay to assess the role of HIV-1 proteins in immune evasion', STAR Protocols, vol. 4,

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, vol. 98, pp. 131 - 139,

Khoo WH; Jackson K; Phetsouphanh C; Zaunders JJ; Alquicira-Hernandez J; Yazar S; Ruiz-Diaz S; Singh M; Dhenni R; Kyaw W; Tea F; Merheb V; Lee FXZ; Burrell R; Howard-Jones A; Koirala A; Zhou L; Yuksel A; Catchpoole DR; Lai CL; Vitagliano TL; Rouet R; Christ D; Tang B; West NP; George S; Gerrard J; Croucher PI; Kelleher AD; Goodnow CG; Sprent JD; Powell JE; Brilot F; Nanan R; Hsu PS; Deenick EK; Britton PN; Phan TG, 2023, 'Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19', Clinical Immunology, vol. 246, pp. 109209,

Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS, 2022, 'Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals', Clinical and experimental immunology, vol. 210, pp. 163 - 174,

Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, vol. 13,

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', eBioMedicine, vol. 84, pp. 104270,

Hastak PS; Andersen CR; Kelleher AD; Sasson SC, 2022, 'Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19', Frontiers in Immunology, vol. 13, pp. 983550,

Papot E; Jacoby S; Arlinda D; Avihingsanon A; Azwa I; Borok M; Brown D; Cisse M; Dao S; Eriobu N; Kaplan R; Karyana M; Kumarasamy N; Losso MH; Matthews GV; Perelis L; Perez-Casas C; Ruxrungtham, K; Watkins M; Lane HC; Kelleher A; Law M; Polizzotto M, 2022, 'Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT', HIV Research & Clinical Practice, vol. 23, pp. 37 - 46,

Agbosu EE; Ledger S; Kelleher AD; Wen J; Ahlenstiel CL, 2022, 'Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection', Pharmaceutics, vol. 14, pp. 1352 - 1352,

Rankin K; Beaton B; Sasson S; Raedemaecker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Patel M; Klemm V; Munier CML; Carey Hoppe A; Tea F; Pillay A; Ospina A; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2022, 'PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA', HemaSphere, vol. 6, pp. 1958 - 1959,

Boyd MA; van Bockel D; Munier CML; Kelleher AD, 2022, 'Navigating the complexity of chronic HIV-1 associated immune dysregulation', Current Opinion in Immunology, vol. 76, pp. 102186,

Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, vol. 7, pp. 896 - 908,

Kelleher AD, 2022, 'Pacific Eclipse: Before the corona dawn', Vaccine, vol. 40, pp. 2474 - 2475,

Duette G; Hiener B; Morgan H; Mazur FG; Mathivanan V; Horsburgh BA; Fisher K; Tong O; Lee E; Ahn H; Shaik A; Fromentin R; Hoh R; Bacchus-Souffan C; Nasr N; Cunningham AL; Hunt PW; Chomont N; Turville SG; Deeks SG; Kelleher AD; Schlub TE; Palmer S, 2022, 'The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells', Journal of Clinical Investigation, vol. 132,

Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL, 2022, 'Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract', International Journal of Molecular Sciences, vol. 23,

Fisher K; Wang XQ; Lee A; Morcilla V; De Vries A; Lee E; Eden JS; Deeks SG; Kelleher AD; Palmer S, 2022, 'Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes', Journal of Virology, vol. 96, pp. e0201121,

Amodio A; Cassani M; Mummolo L; Cortez-Jugo C; Bhangu SK; Symons J; Ahlenstiel CL; Forte G; Ricci F; Kelleher AD; Lewin SR; Cavalieri F; Caruso F, 2022, 'Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA-DNA sensor', Nanoscale, vol. 14, pp. 3049 - 3061,

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2022, 'Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses', Cell Reports, vol. 38, pp. 110345,

Phetsouphanh C; Darley DR; Wilson DB; Howe A; Munier CML; Patel SK; Juno JA; Burrell LM; Kent SJ; Dore GJ; Kelleher AD; Matthews GV, 2022, 'Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection', Nature Immunology, vol. 23, pp. 210 - 216,

Law H; Mach M; Howe A; Obeid S; Milner B; Carey C; Elfis M; Fsadni B; Ognenovska K; Phan TG; Carey D; Xu Y; Venturi V; Zaunders J; Kelleher AD; Munier CML, 2022, 'Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response', iScience, vol. 25, pp. 103656 - 103656,

Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, 'SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', ,

Cook L; Zaunders J; Seddiki N; van Bockel D; Kelleher AD; Munier CML, 2022, 'Parallel analysis of multiple human memory CD4+ T-cell subsets within antigen-specific responses using cell proliferation dyes', Immunology and Cell Biology,

Krishnan A; Ellenberger K; Chansavath P; Kelleher A; Matthews G; Darley D; Holloway C, 2022, 'Myocardial Fibrosis Occurs in Non-Hospitalised Patients With Chronic Symptoms After COVID-19', Heart, Lung and Circulation, vol. 31, pp. S169 - S170,

Loprete J; Katelaris CH; Evans L; Kane A; McMullan B; Wainstein B; Wong M; Post J; Suan D; Swaminathan S; Richardson R; Rogers J; Torda A; Campbell DE; Kelleher AD; Law M; Carr A; Tong WWY, 2022, 'Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study', Journal of Allergy and Clinical Immunology: Global, vol. 1, pp. 99 - 105,

Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC, 2021, 'Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability', Immunity, vol. 54, pp. 2908 - 2921.e6,

Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Hutchings O; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, 2021, 'A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection', npj Vaccines, vol. 6,

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos I; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Zablotska IB; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, vol. 25, pp. 3944 - 3954,

Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher A, 2021, 'Evolution of HIV-1 Surveillance Drug Resistance Mutations over 10 Years in New South Wales, Australia', AIDS Research and Human Retroviruses, vol. 37, pp. 897 - 902,

Phetsouphanh C; Phalora P; Hackstein CP; Thornhill J; Munier ML; Meyerowitz J; Murray L; Vuuren CV; Goedhals D; Drexhage L; Moore R; Sattentau Q; Mak JYW; Fairlie DP; Fidler S; Kelleher A; Frater J; Klenerman P, 2021, 'Human MAIT cells respond to and suppress HIV-1', eLife, vol. 10,

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Stella AO; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', BLOOD, vol. 138,

Mwasakifwa GE; Amin J; Kelleher A; Boyd MA, 2021, 'Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure', AIDS (London, England), vol. 35, pp. 2289 - 2298,

Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I, 2021, 'Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency', Journal of Clinical Immunology, vol. 41, pp. 1915 - 1935,

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', ERJ Open Research, vol. 7, pp. 00384 - 2021,

Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, vol. 22, pp. 605 - 616,

Parsons MS; Kristensen AB; Selva KJ; Lee WS; Amarasena T; Esterbauer R; Wheatley AK; Bavinton BR; Kelleher AD; Grulich AE; Khoury G; Juno JA; Kent SJ, 2021, 'Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure', EBioMedicine, vol. 70, pp. 103518,

Back to profile page